Stämm Biotech raises $17M for its next-generation, 3D printed bioreactor
TechCrunch
FEBRUARY 28, 2022
Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Image Credits: Stämm Biotech. And, as of writing, Ginkgo’s market cap was closer to $7.24 Image Credits: Stämm Biotech.
Let's personalize your content